New insider activity at Conmed ( (CNMD) ) has taken place on February 14, 2025.
CIO Richard Glaze recently executed a sale involving 257 shares of Conmed stock, amounting to a total transaction value of $16,794.
Recent Updates on CNMD stock
Conmed Corporation reported strong growth in its Q4 earnings call, highlighting a 5.8% year-over-year sales increase and significant improvements in adjusted net income. The General Surgery and AirSeal segments showed particularly strong performances, while the Orthopedic segment faced ongoing supply chain challenges. Despite these operational improvements, JPMorgan downgraded Conmed due to a mixed update, where lower than expected guidance for 2025 overshadowed the positive quarterly results. Concerns about continuous execution issues and external pressures such as currency fluctuations and potential tariffs were key factors in the downgrade. Conmed’s management remains focused on overcoming these challenges and maintaining its growth trajectory.
More about Conmed
YTD Price Performance: -7.20%
Average Trading Volume: 432,419
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.93B